New Age Alpha Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133K Sell
4,065
-304
-7% -$10.9K 0.01% 818
2026
Q1
$154K Sell
4,369
-108
-2% -$4.39K 0.01% 652
2025
Q4
$182K Sell
4,477
-244
-5% -$10.6K 0.01% 623
2025
Q3
$222K Sell
4,721
-97
-2% -$5.03K 0.01% 616
2025
Q2
$251K Buy
4,818
+367
+8% +$20.1K 0.01% 587
2025
Q1
$269K Buy
+4,451
New +$287K 0.01% 595

Other funds holding CNMD

New Age Alpha Advisors's CNMD Position: Q2 2026 in Review

New Age Alpha Advisors reduced its CONMED (CNMD) stake by 7% in Q2 2026, selling an estimated $10.9K and leaving 4,065 shares worth $133K. The position accounts for 0.01% of the portfolio, ranked #818.

New Age Alpha Advisors first reported a position in CNMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $269K in Q1 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • New Age Alpha Advisors held 4,065 shares of CONMED worth $133K as of Q2 2026.
  • New Age Alpha Advisors sold 304 CONMED shares in Q2 2026, an estimated $10.9K.
  • CONMED made up 0.01% of New Age Alpha Advisors's portfolio in Q2 2026, its #818 holding.
  • New Age Alpha Advisors first reported a position in CONMED in Q1 2025 and has held it in 6 quarters since.
  • New Age Alpha Advisors's CONMED position peaked at $269K in Q1 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.